Cellyan Biotechnology (HKPD) Cash & Equivalents Growth (1y) (2025 - 2026)

Cellyan Biotechnology (HKPD) Cash & Equivalents Growth (1y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. Growth (1y) (Qtr)
1	Mckesson	102.57 Bn	97.41 Bn	3.69 Bn	113.56%
2	Cencora	61.35 Bn	58.53 Bn	3.61 Bn	26.14%
3	Cardinal Health	54.15 Bn	49.30 Bn	2.56 Bn	25.35%
4	Henry Schein	10.05 Bn	9.89 Bn	1.10 Bn	8.28%
5	Akso Health	671.90 Mn	671.70 Mn	-	-99.89%
6	Edap Tms	154.62 Mn	133.07 Mn	7.34 Mn	12.53%
7	Accendra Health	90.69 Mn	83.04 Mn	263.41 Mn	-80.00%
8	111	31.31 Mn	-27.44 Mn	18.18 Mn	-28.85%
9	Cosmos Health	13.28 Mn	10.84 Mn	1.51 Mn	174.74%
10	Cellyan Biotechnology	6.70 Mn	6.48 Mn	-	-70.39%

Download Data